PSI Journal Club: Treatment Switching in Clinical Trials

The next PSI Journal Club features two papers from Pharmaceutical Statistics on the topic of “Treatment Switching in Clinical Trials”. Please join us on 26 April 2022 from 16:00 to 17:00 BST  to hear Franz König (Medical University of Vienna) and Juliane Manitz (EMD Serono) present their recent work.

The webinar will be chaired by Chrissie Fletcher (GSK). 
This event is sponsored by Wiley. 

The two papers from Pharmaceutical Statistics are:

Franz König (Medical University of Vienna)Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology
Robin Ristl, Nicolás M Ballarini, Heiko Götte, Armin Schüler, Martin Posch & Franz König
Pharmaceutical Statistics. 2021;20:129–145. (OPEN ACCESS)

Juliane Manitz (EMD Serono)Estimands for overall survival in clinical trials with treatment switching in oncology
Juliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, Marie-Laure Casadebaig, Evgeny Degtyarev, Jyotirmoy Dey et al
Pharmaceutical Statistics. 2022;21(1):150-162. (FREE to read)

For each of these published papers there will be a 20 minute presentation by the author followed by a 10 minute discussion.

The two papers are available to view now and presentation slides will be available a week before the JC.  Audio recordings will be available shortly after the JC to download from the PSI website.

The meetings are open to PSI and non-PSI members. The registration link is here.